EyePoint Inc

EYPTStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$3.13

Today

+0.6%

YTD

-82.6%

About

Eyepoint Pharmaceuticals Inc is a global pharmaceutical company focused on the development and commercialisation of therapies for eye-related ailments. Its primary operations are focused on curative treatment, production and distribution. Operating in the biotechnology industry, Eyepoint Pharmaceuticals Inc has a retinal disease-focused pipeline that uses its proprietary Durasert technology to achieve intraocular drug delivery. Its product portfolio includes EYP-1901, an intravitreal anti-VEGF treatment that is targeted at age-related macular degeneration. Its expertise lies in the pharmaceuticals and therapeutics industry. Stay up to date on the share price of EYPT by adding it to your eToro watchlist.

Price chart

Closing price history for EYPT (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-0.84

P/S (TTM)97.74

P/B (TTM)1.61

Market cap$271.57M

Cap tierMicro-cap

Industry avg P/E-7.28

Profitability

Gross margin-18.29%

EBIT margin-11365.22%

Net margin-18633.14%

ROE-148.70%

ROA-115.86%

Earnings & Revenue

Revenue (TTM)$2.79M

Revenue growth (1Y)-94.6%

EPS (TTM)-$3.74

Free cash flow$-271.28M

Total debt$22.37M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)1.51

Employees214

Next earnings4 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.